Lun Wang

ORCID: 0000-0001-5700-3622
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Epigenetics and DNA Methylation
  • RNA Interference and Gene Delivery
  • Cardiac Fibrosis and Remodeling
  • Signaling Pathways in Disease
  • Acute Myocardial Infarction Research
  • Drug Transport and Resistance Mechanisms
  • Allergic Rhinitis and Sensitization
  • Cancer Genomics and Diagnostics
  • IL-33, ST2, and ILC Pathways
  • Cardiac Ischemia and Reperfusion
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Asthma and respiratory diseases

Lianyungang Runzhong Pharmaceutical (China)
2024

Chinese Academy of Medical Sciences & Peking Union Medical College
2022-2023

Peking Union Medical College Hospital
2022-2023

Circulating proteomic signatures of age are closely associated with aging and age-related diseases; however, the utility changes in secreted proteins identifying therapeutic targets for diseases remains unclear. Serum profiling an age-stratified healthy population further community-based cohort together heart failure patients study demonstrated that circulating C-C motif chemokine ligand 17 (CCL17) level increased correlated cardiac dysfunction. Subsequent animal experiments revealed...

10.1084/jem.20200418 article EN cc-by The Journal of Experimental Medicine 2022-06-10

Generalist Large Language Models (LLMs), such as GPT-4, have shown considerable promise in various domains, including medical diagnosis. Rare diseases, affecting approximately 300 million people worldwide, often unsatisfactory clinical diagnosis rates primarily due to a lack of experienced physicians and the complexity differentiating among many rare diseases. In this context, recent news "ChatGPT correctly diagnosed 4-year-old's disease after 17 doctors failed" underscore LLMs' potential,...

10.48550/arxiv.2402.06341 preprint EN arXiv (Cornell University) 2024-02-09
Coming Soon ...